Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 19Recruiting 11Terminated 5Withdrawn 3Unknown 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Genitourinary 1

Conditions

Brain Neoplasms 2Recurrence 1Prostatic Neoplasms 1Neoplasms 1Glioma 1Glioblastoma 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × fluciclovine F-18 × Clear all
NCT03925675 2024-09-03

18F-Fluciclovine PET and Multiparametric MR Imaging

Loma Linda University

Phase 2 Withdrawn
CNS

Brain Neoplasms, Recurrence

NCT05035732 2024-01-18

A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)

M.D. Anderson Cancer Center

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT05054400 2023-09-01

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡